Research News and Research

RSS

Findings demonstrate direct correlation between improved air quality and pediatric ear infections

A new study by researchers at UCLA and Brigham and Women's Hospital in Boston suggests that improvements in air quality over the past decade have resulted in fewer cases of ear infections in children.

28 Jan 2010

People with early-stage lung cancer may double their chances of surviving by giving up smoking

People with early-stage lung cancer may double their chances of surviving for longer than five years by giving up smoking, UK scientists have found.

28 Jan 2010

Increased cost sharing may hurt seniors' health care

Cost sharing and increased co-pays, even if it's just a few dollars, can lead seniors to put off visits to the doctor and result in increased hospital admissions and longer hospital stays, according to a new study.

28 Jan 2010

Conatus Pharmaceuticals initiates combination trial of CTS-1027 with pegylated interferon and ribavirin for HCV

Conatus Pharmaceuticals Inc. announced today the initiation of a Phase II clinical trial evaluating CTS-1027 in combination with pegylated interferon (Pegasys®) and ribavirin (Copegus®) in refractory HCV patients. Antiviral activity, safety and tolerability of the triple combination will be assessed after up to 48 weeks of therapy.

28 Jan 2010

Rotavirus vaccine could save millions of children in developing countries, studies find

Efforts to vaccinate "infants against rotavirus could save the lives of millions of children in developing nations who would otherwise die from the diarrhea-causing disease, two new studies show," HealthDay/BusinsessWeek reports.

28 Jan 2010

Life Technologies collaborates with Ignite Institute to create genomic sequencing center

Life Technologies Corporation and the Ignite Institute for Individualized Health announced today a collaboration to create a ground-breaking genomic sequencing center at Ignite’s new facility in Northern Virginia.

28 Jan 2010

Jeffrey Modell Foundation urges government to implement SCID screening for all newborns

Vicki and Fred Modell, co-founders of the Jeffrey Modell Foundation, today called upon governors, state public health officials, and legislators, in all states, to implement screening of newborns with Severe Combined Immune Deficiency (SCID).

28 Jan 2010

Tornier and LifeCell commence enrollment in Conexa Reconstructive Tissue Matrix clinical trial

Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.

28 Jan 2010

Alcohol increases risk of violence in couples, says study

Alcohol increases the risk of violence in couples — especially violence both to and by the female partner. A new study of couples found that experienced intimate partner violence found 30.2 percent reported alcohol use before or during the event.

28 Jan 2010

Innovative cardiac scanner allows early detection of heart conditions

The portable magnetometer is being developed at the University of Leeds, with funding from the Engineering and Physical Sciences Research Council (EPSRC) playing a key role.

28 Jan 2010

Novella Clinical and OSI Pharmaceuticals expand existing clinical service agreement

Novella Clinical Inc. (formerly PharmaLinkFHI) and OSI Pharmaceuticals, Inc. announced today that the Companies will expand their existing clinical service agreement. Under the terms of the new agreement, effective February 1, 2010, Novella will provide clinical research and related services to OSI for a period of two years as OSI transitions its clinical operations to its new Ardsley, New York campus. Novella will assume use of some of OSI’s facilities in Boulder and employ members of OSI’s Boulder staff.

28 Jan 2010

NIDA supports Omeros' Addiction program

Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company's Addiction program. NIDA will fund substantially all of the costs of a Phase 2 clinical study to be conducted by New York State Psychiatric Institute researchers.

28 Jan 2010

Most Britons not aware of the dangers of alcohol misuse

A government-funded advertising campaign launching today, backed by Cancer Research UK and other major health charities, aims to raise awareness of the unseen health damage caused by regular alcohol misuse.

28 Jan 2010

Kensey Nash announces financial results for second quarter of fiscal year 2010

Kensey Nash Corporation, a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today reported the results for its three and six months ended December 31, 2009.

28 Jan 2010

Life Technologies reports fourth-quarter and fiscal year results ended December 31, 2009

Life Technologies Corporation today announced results for its fourth quarter and full year ending December 31, 2009. Non-GAAP revenue for the fourth quarter was $874 million, resulting in full year non-GAAP revenues of $3.30 billion, an increase of 5 percent over the $3.14 billion reported for 2008, as if Invitrogen and Applied Biosystems had been combined.

From Danaher 28 Jan 2010

Celgene reports total revenue of $758M for fourth-quarter of 2009

Celgene Corporation announced non-GAAP (Generally Accepted Accounting Principles) net income of $290.3 million, or non-GAAP diluted earnings per share of $0.62 for the quarter ended December 31, 2009. Non-GAAP net income for the fourth quarter of 2008 was $200.9 million or non-GAAP diluted earnings per share of $0.43. Based on U.S. GAAP, Celgene reported net income of $254.2 million, or diluted earnings per share of $0.54 for the quarter ended December 31, 2009. GAAP net loss for the fourth quarter of 2008 was $149.3 million, or diluted loss per share of $0.33.

28 Jan 2010

Cenduit announces strategic business alliance with invivodata

Cenduit, LLC, and invivodata, inc., today announce a strategic business alliance to further improve clinical trial efficiencies by adding the scientific and operational benefits of invivodata’s electronic Patient Reported Outcomes (ePRO) solutions to the proven efficiencies of Cenduit‘s Interactive Response Technology solution (IRT).

28 Jan 2010

AAOS, SOMOS, and OTA host EWI symposium on improving patient care for wounded warriors

Since the beginning of Operations Iraqi Freedom and Enduring Freedom, there have been nearly 36,000 battle- injured warriors, of which approximately 82 percent suffer extremity trauma. Many of these injuries are complicated by the effects of improvised explosive devices which cause injury patterns distinct from civilian trauma. Traditional wound-management guidelines simply fall short.

28 Jan 2010

Study shows guilt feelings are more pronounced in older women

Although changing social and cultural contexts mean guilt has less power today than it once did, a new study has shown that in the West this emotion is "significantly higher" among women. The main problem, according to the experts, is not that women feel a lot of guilt (which they do), but rather that many males feel "too little".

28 Jan 2010

Scientists discover mechanism that regulates prolactin hormone

A mechanism for regulating the hormone prolactin has newly been revealed by scientists at Karolinska Institutet. The results are to be published in the scientific journal Neuron, and may be significant for conditions and functions such as breast-feeding, sexual libido, and metabolism.

28 Jan 2010

Research News and Research

Findings demonstrate direct correlation between improved air quality and pediatric ear infections

People with early-stage lung cancer may double their chances of surviving by giving up smoking

Increased cost sharing may hurt seniors' health care

Conatus Pharmaceuticals initiates combination trial of CTS-1027 with pegylated interferon and ribavirin for HCV

Rotavirus vaccine could save millions of children in developing countries, studies find

Life Technologies collaborates with Ignite Institute to create genomic sequencing center

Jeffrey Modell Foundation urges government to implement SCID screening for all newborns

Tornier and LifeCell commence enrollment in Conexa Reconstructive Tissue Matrix clinical trial

Alcohol increases risk of violence in couples, says study

Innovative cardiac scanner allows early detection of heart conditions

Novella Clinical and OSI Pharmaceuticals expand existing clinical service agreement

NIDA supports Omeros' Addiction program

Most Britons not aware of the dangers of alcohol misuse

Kensey Nash announces financial results for second quarter of fiscal year 2010

Life Technologies reports fourth-quarter and fiscal year results ended December 31, 2009

Celgene reports total revenue of $758M for fourth-quarter of 2009

Cenduit announces strategic business alliance with invivodata

AAOS, SOMOS, and OTA host EWI symposium on improving patient care for wounded warriors

Study shows guilt feelings are more pronounced in older women

Scientists discover mechanism that regulates prolactin hormone

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News